Literature DB >> 16520807

Genetic mapping of a 17q chromosomal region linked to obesity phenotypes in the IRAS family study.

B S Sutton1, C D Langefeld, J K Campbell, S M Haffner, J M Norris, A L Scherzinger, L E Wagenknecht, D W Bowden.   

Abstract

OBJECTIVE: Obesity is widely accepted to be influenced by both environmental and genetic factors. Several recent studies have used the positional cloning approach in an attempt to discover genes contributing to obesity. In the IRAS Family Study a genomewide scan was performed on 1425 individuals of Hispanic descent (90 extended pedigree families) to identify regions of the genome linked to obesity phenotypes.
METHODS: Nonparametric QTL linkage analysis was performed using a variance components approach. The genome scan was performed in two phases: an initial genome scan in 45 families and a replication scan in 45 families. Fine mapping and candidate gene analyses were also performed. General estimating equations (GEE1) and quantitative pedigree disequilibrium tests (QPDT) were used for association analysis of single SNP and haplotype data.
RESULTS: Evidence for linkage to obesity traits was observed in each scan on the long arm of chromosome 17. When data from both scans was combined, a region on chromosome 17q was identified with evidence of linkage to visceral adipose tissue (VAT; LOD 3.11), waist circumference (WAIST) (LOD 2.5) and body mass index (BMI) (LOD 2.81). Nine additional microsatellite markers were identified and genotyped on all Hispanic individuals, with a mean marker density of approximately 1 marker/3 cM. Evidence of linkage remained significant with LOD 3.05 for VAT, LOD 2.44 for BMI and LOD 1.92 for WAIST. Fine mapping analyses suggest the possibility of two different obesity loci. In addition, the LOD - 1 interval of the major VAT peak decreased from 83-108 to 95-111 cM. Three positional candidate genes under the peak: somatostatin receptor 2 (SSTR2), galanin receptor 2 (GALR2), and growth hormone bound protein receptor 2 (GRB2) were chosen for detailed evaluation. Multiple polymorphisms within each candidate were genotyped and tested for association with the obesity phenotypes. Little evidence of association was detected between polymorphisms and obesity traits.
CONCLUSION: In conclusion, replication of linkage and fine mapping suggest that a region on chromosome 17q contains a gene (or genes) that contributes to the genetic etiology of obesity with the strongest evidence for linkage to VAT. Candidate genes in the region do not appear to account for the evidence of linkage. Additional studies are necessary to identify the obesity-related polymorphisms.

Entities:  

Mesh:

Year:  2006        PMID: 16520807     DOI: 10.1038/sj.ijo.0803298

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  5 in total

1.  PRKCA: a positional candidate gene for body mass index and asthma.

Authors:  Amy Murphy; Kelan G Tantisira; Manuel E Soto-Quirós; Lydiana Avila; Barbara J Klanderman; Stephen Lake; Scott T Weiss; Juan C Celedón
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

2.  Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.

Authors:  Matthew E Talbert; Carl D Langefeld; Julie Ziegler; Josyf C Mychaleckyj; Steven M Haffner; Jill M Norris; Donald W Bowden
Journal:  Hum Genet       Date:  2008-12-13       Impact factor: 4.132

Review 3.  The role of progranulin in diabetes and kidney disease.

Authors:  Bruna Bellincanta Nicoletto; Luis Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2015-12-21       Impact factor: 3.320

4.  Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: the Insulin Resistance Atherosclerosis Family Study.

Authors:  Beth S Sutton; Nicholette D Palmer; Carl D Langefeld; Bingzhong Xue; Alexandria Proctor; Julie T Ziegler; Steven M Haffner; Jill M Norris; Donald W Bowden
Journal:  Diabetes       Date:  2009-03-26       Impact factor: 9.461

5.  Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes.

Authors:  Tom G Richardson; Camelia Minica; Jon Heron; Jeremy Tavare; Alasdair MacKenzie; Ian Day; Glyn Lewis; Matthew Hickman; Jacqueline M Vink; Joel Gelernter; Henry R Kranzler; Lindsay A Farrer; Marcus Munafò; David Wynick
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-09-16       Impact factor: 3.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.